Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00753181 · ClinicalTrials.gov registry record · Phase 3
Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT00753181 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 60 participants.
The verdict
NCT00753181, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
To evaluate average daily blood glucose in subjects with type 2 diabetes following a Meal Plan including Diabetes-Specific products compared to average daily blood glucose in subjects following their usual diet.
Interventions
- OTHER Usual diet
- OTHER Nutritional Formula
- OTHER Diabetes Meal Plan with experimental diabetes-specific nutritional shake, diabetes specific cereal, and diabetes specific snack bars.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00753181
The ClinicalTrials.gov registry entry for NCT00753181 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Usual diet is the first listed.
NCT00753181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00753181 about?
NCT00753181 is a clinical study titled "Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes". To evaluate average daily blood glucose in subjects with type 2 diabetes following a Meal Plan including Diabetes-Specific products compared to average daily blood glucose in subjects following their usual diet.
What is the current status of trial NCT00753181?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2008-08. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00753181?
The interventions under investigation include: Usual diet (OTHER), Nutritional Formula (OTHER), Diabetes Meal Plan with experimental diabetes-specific nutritional shake, diabetes specific cereal, and diabetes specific snack bars. (OTHER).
Who is sponsoring clinical trial NCT00753181?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.